Hyperliquid Strategies, Inc. (PURR)

12.18 -0.59 (-4.62%) USD  |  NASDAQ  |  Sep 04, 16:00
12.11 -0.07 (-0.57%) After-Hours: 20:00
More

Hyperliquid Strategies EPS Diluted (Quarterly) : 2.102 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for PURR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 2.102
March 31, 2026 1.011
December 31, 2025 -2.454
Date Value
September 30, 2025 -0.0098
June 30, 2025 -0.0048

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Strive, Inc. (United States) -3.770
Meridian Holdings, Inc. (California) 0.00
ACADIA Pharmaceuticals, Inc. 0.1822
Agenus, Inc. -0.0146
Alnylam Pharmaceuticals, Inc. 1.207

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) 470.89M
Revenue (Quarterly) 6.334M
Total Expenses (Quarterly) -464.56M
Enterprise Value 2.305B
Earnings Yield 5.33%
Normalized Earnings Yield -15.21